TrialThe Journal of antimicrobial chemotherapy2016

Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.

D N Gerding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.